The Global Nonalcoholic Fatty Liver Disease (NAFLD) Therapeutics Market is evolving rapidly, driven by the increasing prevalence of obesity, type 2 diabetes, and metabolic syndrome. NAFLD, a chronic liver condition characterized by the buildup of fat in the liver without significant alcohol consumption, has become a global health challenge. With advancements in therapeutics and diagnostics, the...